DocGo (DCGO) Research & Development (2021 - 2026)

DocGo (DCGO) has reported Research & Development for 6 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development rose 1.8% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $13.6 million (up 6.14% YoY), while the FY2025 annual figure was $13.6 million, up 17.03% from the prior year.
• Research & Development came in at $3.7 million for Q1 2026 at DocGo, down from $3.8 million in the prior quarter.
• The five-year high for Research & Development was $3.8 million in Q4 2025, with the low at $1.1 million in Q1 2022.
• Average Research & Development over 5 years is $2.7 million, with a median of $3.0 million recorded in 2025.
• Across the five-year window, Research & Development soared 135.61% in 2023 and slipped 7.98% in 2024, its largest moves.
• Year by year, Research & Development stood at $1.7 million in 2022, then soared by 85.03% to $3.2 million in 2023, then increased by 15.7% to $3.7 million in 2024, then gained by 2.37% to $3.8 million in 2025, then declined by 1.8% to $3.7 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $3.7 million, $3.8 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.